Establishment Labs Inc. (ESTA)
Company Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name.
It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution.
The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally.
Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Country | CR |
IPO Date | Jul 19, 2018 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 933 |
CEO | Rajbir Singh Denhoy |
Contact Details
Address: Building B15 and 25 Alajuela, CR | |
Website | https://www.establishmentlabs.com |
Stock Details
Ticker Symbol | ESTA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001688757 |
CUSIP Number | G31249108 |
ISIN Number | VGG312491084 |
Employer ID | 98-1436377 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Rajbir Singh Denhoy | Chief Financial Officer |
Roberto de Mezerville | Chief Technology Officer |
Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
Jeff Ehrhardt | Senior Vice President & GM of North America |
Neeta Toprani | Corporate Secretary |
Rosalyn Cole d'Incelli | SVice President of Global Clinical, Medical & US Regulatory Affairs |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 28, 2025 | S-8 | Filing |
Feb 28, 2025 | 10-K | Annual Report |
Feb 26, 2025 | 8-K | Current Report |
Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 11, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Jan 16, 2025 | 8-K | Current Report |
Jan 13, 2025 | 8-K | Current Report |
Jan 03, 2025 | 4 | Filing |